Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

TSE:HLS Stock Latest News

Company AnnouncementsHLS Therapeutics Sets November 12 Date for Q3 2026 Results Call3d ago
HLS Therapeutics upgraded to Strong Buy from Outperform at Raymond JamesThe FlyHLS Therapeutics upgraded to Strong Buy from Outperform at Raymond James2M ago
RatingsHLS Therapeutics Earns Reiterated Buy Rating from David Martin on Strong 2Q Results and Clozaril Recovery; C$12 Price Target Maintained2M ago
Pre-EarningsIs HLS a Buy, Before Earnings?2M ago
HLS Therapeutics: Near-Term Softness Masking NILEMDO-Driven Growth Upside, Supporting Buy RatingRatingsHLS Therapeutics: Near-Term Softness Masking NILEMDO-Driven Growth Upside, Supporting Buy Rating7M ago
The FlyHLS Therapeutics price target lowered to C$4.45 from C$4.75 at Stifel7M ago
Company AnnouncementsHLS Therapeutics Lifts Profitability, Cuts Debt as It Expands Cardiovascular Portfolio7M ago
HLS Therapeutics price target raised to C$4.75 from C$4 at StifelThe FlyHLS Therapeutics price target raised to C$4.75 from C$4 at Stifel10M ago
RatingsPositive Outlook for HLS Therapeutics Inc. Amid Regulatory Developments and Product Approvals11M ago
Company AnnouncementsHLS Therapeutics Gains Health Canada Approval for NILEMDO®11M ago